Skip to main content
SpringerLink
Log in

Differential Protection and Recovery of 5-HT1A Receptors from N-Ethoxycarbonyl-2-Ethoxy-1, 2-Dihydroquinoline (EEDQ) Inactivation in Regions of Rat Brain

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

The effect of N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) on 5-HT1A receptors was studied in Sprague Dawley rats. A single dose of EEDQ (4 mg/kg body wt., i.p.) significantly inactivated 5-HT1A receptors, as measured by [3H]8-hydroxy-2-[di-n-propylamino]-tetralin ([3H]8-OH-DPAT), in cortex (64%, p < 0.0001) and hippocampus (48%, p < 0.0001). A significant (p < 0.01) increase in the affinity of 5-HT1A receptors for radioligand was observed in both regions. A dose dependent protection of cortical 5-HT1A receptors from EEDQ inactivation with pre-treatment of different doses of 8-OH-DPAT (4–20 mg/kg) was observed, along with recovery of affinity of [3H]8-OH-DPAT for 5-HT1A receptors in both regions. Although, a dose of 4 mg/kg of 8-OH-DPAT failed to attenuate the effect of EEDQ on hippocampal 5-HT1A receptors, a significant protection of these receptors was observed with 10 and 20 mg/kg of 8-OH-DPAT. Displacement studies revealed that EEDQ has more affinity for cortical (Ki = 101.3 ± 11.8 nM) than hippocampal (Ki = 133.5 ± 25.8 nM) 5-HT1A receptors. A time dependent natural recovery of 5-HT1A receptors from inactivation by a single dose of EEDQ (4 mg/kg) was observed more in cortex compared to hippocampus over a period from 1 day to 14 days. The results of this study suggest that 8-OH-DPAT inhibited EEDQ inactivation of cortical and hippocampal 5-HT1A receptors in a concentration dependent manner. The synthesis and turnover of 5-HT1A receptors differ in cortex and hippocampus, as evident by earlier recovery in the cortex.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Humphrey, P. P. A., Hartig, P., and Hoyer, D. 1993. A prepared new nomenclature for 5-HT receptors. Trend. Pharmacol. Scien. 14:223–236.

    Google Scholar 

  2. Lieberman, J. A., Mailman, R. B., Duncan, G., Sikich, L., Chakoc, M., Nichols, D. E., and Kraus, J. E. 1998. Serotonergic basis of antipsychotic drug effects in schizophrenia. Biol. Psychiat. 44:1099–1117.

    Google Scholar 

  3. Chaput Y., deMontigney, C., and Blier, P. 1991. Presynaptic and post-synaptic modifications of the serotonin system by long-term administration of antidepressant treatment. An in vivo electrophysiological study in the rat. Neuropsychopharmacol. 5:219–229.

    Google Scholar 

  4. Subhash, M. N., Vinod, K. Y., and Srinivas, B. N. 1999. Differential effect of lithium on 5-HT1 receptor-linked system in regions of rat brain. Neurochem. Int. 35:337–343.

    Google Scholar 

  5. Nenonene, E. K., Radja, F., Carli, M., Grondin, L., and Reader, T. A. 1994. Heterogeneity of cortical and hippocampal 5-HT1A receptors: A appraisal of homogenate binding with 8-[3H]-OH-propylaminotetralin. J. Neurochem. 62:1822–1834.

    Google Scholar 

  6. Hamon, M., Emerit, M. B., El Mestikawy, S., Gallissot, M. C., and Gozlan, H. 1989. Regional differences in the transduction mechanism of 5-hydroxytryptamine receptors in the mammalian brain, pages 41–59. in Saxena P. R., Wallis D. I., Wouters W. and Bevan P. (eds.) Cardiovascular pharmacology of 5-hydroxytryptamine. Kluwer Academic Dordech.

  7. Alder, C. H., Meller, E., and Goldstein, M. 1985. Recovery of α2-adrenoceptor binding and function after irreversible inactivation by EEDQ. Eur. J. Pharmacol. 116:175–178.

    Google Scholar 

  8. Neve, K. and Molinoff, P. 1986. Turnover of α-1 and α-2 adrenergic receptors after downregulation of irreversible blockade. Mol. Pharmacol. 30:104–111.

    Google Scholar 

  9. Pilc, A. and Vitulani, J. 1990. Pretreatment with EEDQ accelerates the electroshock-induced decrease in density of β-adrenoreceptors but not functional downregulation. Neuropharmacol. 29: 169–473.

    Google Scholar 

  10. Gnanlingam K. K., Hunter A. J., Janner P., and Marsenden D. 1994. An autoradiographic study of differential effects of EEDQ on striatal and extrastriatal D1 and D2 receptors in rats. Neuropharmacol. 33:647–655.

    Google Scholar 

  11. Meller, E., Bohmaker, K., Goldstein, M., and Friedhoff, J. 1985. Inactivation of D1 and D2 dopamine receptors by EEDQ in vivo: selective protection by neuroleptics. J. Pharmacol. Expt. Therp. 233:656–662.

    Google Scholar 

  12. Norman, A. B. and Creese, I. 1986. Effect of in vivo and in vitro treatment with EEDQ on putative muscarinic receptor subtypes in rat brain. Mol. Pharmacol. 30:96–103.

    Google Scholar 

  13. Gozlan, H., Laporte, A. M., Thibault, S., Schechter, L. E., Bolanos, F., and Hamon, M. 1994. Differential effects of EEDQ on various 5-HT receptor binding sites in rat brain. Neuropharmacol. 33:423–431.

    Google Scholar 

  14. Keck, B. J. and Lakoski, J. M. 1996. Region specific serotonin1A receptor turnover following irreversible blockade with EEDQ. Neuropharmacol. 7:2717–2721.

    Google Scholar 

  15. Subhash, M. N., Srinivas, B. N., Vinod, K. Y., and Jagadeesh, S. 1998. Inactivation of 5-HT1A and [3H]5-HT binding sites by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) in rat brain. Neurochem. Res. 23:1321–1326.

    Google Scholar 

  16. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:265–275.

    Google Scholar 

  17. Peroutka, S. J. 1986. Pharmacological characterization and differentiation of 5-HT1A, 5-HT1B and 5-HT1C binding sites in rat frontal cortex. J. Neurochem. 57:529–540.

    Google Scholar 

  18. McPherson, G. A. 1983. A partial computer-based ligand approach to the analysis of radioligand binding experiments. Comput. Prog. Biomed. 17:107–114.

    Google Scholar 

  19. Keck, B. J. and Lakoski, J. M. 1997. EEDQ administration for studies of 5-HT1A receptor binding site inactivation and turnover. Brain Res. Protocol 1:364–370.

    Google Scholar 

  20. Nenonene, E. K., Carli, M., Vangelder, N. M., Aftkhamidastjerdian, S., and Reader, T. A. 1996. Alkylation of [3H]8-OHDPAT binding sites in rat cerebral cortex and hippocampus. Neurochem. Res. 21:167–176.

    Google Scholar 

  21. Takahashi, Y., Kusumi, I., Ishikane, T., and Kayama, T. 1998. In vivo occupation of D1, D2 and Serotonin-2A receptor by novel antipsyhotic drug, SM-9018 and its metabolite in rat brain. J. Neural Transm. 105:181–191.

    Google Scholar 

  22. Hamon, M., Fattaccini, C. H., Adrien, J., Gallisot, M. C., Martin, P., and Gozlan, H. 1988. Alterations of central serotonin and dopamine turnover in rats treated with ipsaperone and other 5-HT1A antagonists with anxiolytic properties. J. Pharmacol. Expt. Therp. 24:745–752.

    Google Scholar 

  23. Sharp, I., Backhs, L. L., Hjorth, S., Branwell, S. R., and Gahame-Smith, D. G. 1990. Further inactivation of the in vivo pharmacological properties of putative 5-HT1A antagonist BMY 7378. Eur. J. Pharmacol. 176:331–340.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurochemistry, National Institute of Mental Health and Neurosciences, Bangalore, 29, India

    K. Y. Vinod, M. N. Subhash & B. N. Srinivas

Authors
  1. K. Y. Vinod
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. N. Subhash
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. N. Srinivas
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vinod, K.Y., Subhash, M.N. & Srinivas, B.N. Differential Protection and Recovery of 5-HT1A Receptors from N-Ethoxycarbonyl-2-Ethoxy-1, 2-Dihydroquinoline (EEDQ) Inactivation in Regions of Rat Brain. Neurochem Res 26, 113–120 (2001). https://doi.org/10.1023/A:1011038510723

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011038510723

Search

Navigation